Genedata AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genedata AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10886
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, genedata screener, genedata expressionist, genedata philosopher, genedata analyst and genedata selector. Genedata provides services such as information technology services, data analysis, custom software development, training, and hosting. The company also offers support and training services. It serves pharma, bio-pharma, agribusiness, industrial biotech, food and beverage, and other sectors. The company has presence in Switzerland, Germany, the US and Japan. Genedata is headquartered in Basel, Switzerland.

Genedata AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genedata AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genedata AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genedata AG, Medical Devices Deals, 2012 to YTD 2018 9
Genedata AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genedata AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Genedata Enters into Integration Agreement with IntelliCyt 11
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 12
Genedata Enters Into Technology Integration Agreement With Life Technologies 13
Licensing Agreements 14
F-star Biotech Enters into Licensing Agreement with Genedata 14
Genedata Enters into Licensing Agreement with Pfizer 15
Ono Pharma Enters Into Licensing Agreement With Genedata For Genedata Expressionist 16
Takeda Expands Licensing Agreement With Genedata For Genedata Expressionist 17
Roche Extends Licensing Agreement With Genedata 18
Chugai Pharma Extends Licensing Agreement With Genedata For Genedata Expressionist Software 19
Genedata AG – Key Competitors 20
Genedata AG – Key Employees 21
Genedata AG – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Strategy And Business Planning 23
Feb 21, 2017: Genedata Expands Into United Kingdom 23
Financial Announcements 24
Aug 20, 2018: Aptevo Therapeutics deploys Genedata Biologics to streamline Cancer Immunotherapy R&D 24
Government and Public Interest 25
Jul 10, 2018: MyBio Adopts Genedata for Improving Antibiotic Production Processes 25
Product News 26
Jun 06, 2017: Genedata Announces New Solution for Efficient Analysis of High-Throughput Automated Patch Clamp Experiments 26
Feb 02, 2018: Genedata Profiler Powers Major Breakthroughs in Early Prediction of Breast and Ovarian Cancer 27
Jan 31, 2018: Genedata Announces Genedata Screener for Massive Mechanistic Analysis 28
Other Significant Developments 29
Oct 02, 2018: Genedata Bioprocess Offers Out-of-the-Box Integration with ambr Bioreactors 29
Feb 27, 2018: Sanofi Adopts Genedata Selector to Optimize Strain Development 30
Jan 11, 2018: Genedata Announces New Solution for CRISPR Data Management and Analysis 31
Dec 20, 2017: Genedata Profiler Moves to High-Performance Clouds 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Genedata AG, Pharmaceuticals & Healthcare, Key Facts 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genedata AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genedata AG, Deals By Therapy Area, 2012 to YTD 2018 8
Genedata AG, Medical Devices Deals, 2012 to YTD 2018 9
Genedata AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genedata Enters into Integration Agreement with IntelliCyt 11
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 12
Genedata Enters Into Technology Integration Agreement With Life Technologies 13
F-star Biotech Enters into Licensing Agreement with Genedata 14
Genedata Enters into Licensing Agreement with Pfizer 15
Ono Pharma Enters Into Licensing Agreement With Genedata For Genedata Expressionist 16
Takeda Expands Licensing Agreement With Genedata For Genedata Expressionist 17
Roche Extends Licensing Agreement With Genedata 18
Chugai Pharma Extends Licensing Agreement With Genedata For Genedata Expressionist Software 19
Genedata AG, Key Competitors 20
Genedata AG, Key Employees 21
Genedata AG, Subsidiaries 22

List of Figures
Genedata AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genedata AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genedata AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genedata AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Genedata AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • A. K. Capital Services Ltd (530499):企業の財務・戦略的SWOT分析
    A. K. Capital Services Ltd (530499) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Eurobio Scientific SA (ALERS):企業の製品パイプライン分析
    Summary Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic infection. …
  • Groupe Galeries Lafayette:戦略・SWOT・企業財務分析
    Groupe Galeries Lafayette - Strategy, SWOT and Corporate Finance Report Summary Groupe Galeries Lafayette - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • EBTEC Corporation:企業の戦略・SWOT・財務分析
    EBTEC Corporation - Strategy, SWOT and Corporate Finance Report Summary EBTEC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • EnWave Corp (ENW):企業の財務・戦略的SWOT分析
    EnWave Corp (ENW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • TGS-NOPEC Geophysical Company ASA (TGS):石油・ガス:M&Aディール及び事業提携情報
    Summary TGS-NOPEC Geophysical Company ASA (TGS) is a provider of exploration services. It offers multi-client geosciences data to oil and gas exploration and production companies. The company offers a range of global geophysical and geological data libraries including multi-client seismic data, magn …
  • GEO Specialty Chemicals Inc:企業の戦略的SWOT分析
    GEO Specialty Chemicals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Gulf Oil Limited Partnership:企業の戦略的SWOT分析
    Gulf Oil Limited Partnership - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Pinnacle Investment Management Group Ltd (PNI):企業の財務・戦略的SWOT分析
    Pinnacle Investment Management Group Ltd (PNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • DRDGOLD Ltd:企業の戦略・SWOT・財務情報
    DRDGOLD Ltd - Strategy, SWOT and Corporate Finance Report Summary DRDGOLD Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Baoding Lightway Green Energy Technology Co Ltd:企業の戦略的SWOT分析
    Baoding Lightway Green Energy Technology Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Sabine Oil & Gas Corporation-石油・ガス分野:企業M&A・提携分析
    Summary Sabine Oil & Gas Corporation (Sabine Oil), formerly known as Forest Oil Corporation is an independent oil and gas company. The company focuses on acquisition, exploitation, development and exploration of oil and natural gas properties onshore in the US. Its core areas of operations include E …
  • Medicines for Malaria Venture:製薬・医療:M&Aディール及び事業提携情報
    Summary Medicines for Malaria Venture (MMV) is a drug developing company that discovers and delivers new, effective and affordable antimalarial drugs. The center provides products that offers efficacy against drug-resistant strains of plasmodium falciparum, potential for intermittent treatments, saf …
  • Next Fifteen Communications Group plc:企業のM&A・事業提携・投資動向
    Next Fifteen Communications Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Next Fifteen Communications Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Central Bank of Egypt:企業の戦略的SWOT分析
    Central Bank of Egypt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Ashok Leyland Limited:企業の戦略・SWOT・財務分析
    Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report Summary Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Centric Health Corp (CHH):企業の財務・戦略的SWOT分析
    Summary Centric Health Corp (CHC) is a healthcare and wellness service provider. The company operates through specialty pharmacy, orthotics, and surgical and medical centres. Its pharmacies provide traditional pharmacy services such as compounding and dispensing medications, and clinical and special …
  • Menasha Corporation:企業の戦略・SWOT・財務分析
    Menasha Corporation - Strategy, SWOT and Corporate Finance Report Summary Menasha Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Esperion Therapeutics Inc (ESPR)-製薬・医療分野:企業M&A・提携分析
    Summary Esperion Therapeutics Inc (Esperion) is a pharmaceutical company that develops and commercializes oral therapies to treat patients with elevated low-density lipoprotein cholesterol (LDL-C). The company’s lead product candidate, Bempedoic acid, an ATP-citrate lyase inhibitor which is in Phase …
  • Google LLC:企業の戦略的SWOT分析
    Google LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆